Nanotoxicology News

RSS

Chemicals in Tea as Building Blocks for Production of Biocompatible Gold Nanoparticles

Researchers from the University of Missouri-Columbia report in the Journal of Materials Chemistry that chemicals in tea are the best yet discovered to make consistent, biologically safe gold nanoparticles. More important...

27 Apr 2009

A Nanoparticle Platform that has the Potential to Target, Image, and Treat Cancer

Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, a...

27 Apr 2009

Advances in Nanotechnology Require New Oversight

Existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of advancing nanotechnology.

27 Apr 2009

Thermo Fisher Scientific Wins Queens Award for Enterprise 2009

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Cambridge facility has been awarded a Queens Award for Enterprise 2009 in the Outstanding Innovation category for the iCAP 6000 Series ICP-OES instrument.

27 Apr 2009

SERS of TiO2 Nanoparticles

Surface-enhanced Raman scattering (SERS) spectroscopy has the potential to allow single-molecule detection sensitivity. This capability presents new approaches for studying the biophysical and biomedical properties of complex biologically relevant systems in situ.

24 Apr 2009

UAlbany Connections Lead Physician to Success

When Dr. Sara Brenner first met Barack Obama, she was on a mission to make disease prevention a higher priority in federal health policy. Little did she know she was speaking with the future President of the United States.

24 Apr 2009

Nanoparticle that Transports Antitumor Genes Selectively to Cancer Cells

Cancer researchers have been exploring gene therapy as an experimental treatment to fight the deadly disease despite the obstacles that have surfaced along the way. A cross-European research team has now gained a foothold in this area by developing a nanoparticle that transports antitumor genes selectively to cancer cells.

23 Apr 2009

BioAlliance Pharma Presents Results on New Biotherapy at AACR Annual Meeting

BioAlliance Pharma SA (Paris:BIO), a specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, has presented results on its new biotherapy, plasmid AMEP™, for metastatic melanoma treatment at the at the American Association for Cancer Research (AACR) 100th Annual Meeting, in Denver, April 18 to 22, 2009.

22 Apr 2009